兰地洛尔治疗脓毒症相关性快速心律失常的疗效：翻译之失。 - Suppr | 超能文献

相似文献

1

Efficacy of Landiolol for Treatment of Sepsis-Related Tachyarrhythmia: Lost in Translation.兰地洛尔治疗脓毒症相关性快速心律失常的疗效：翻译之失。

Am J Cardiovasc Drugs. 2025 Jun 8. doi: 10.1007/s40256-025-00736-x.

2

Efficacy and Safety of Landiolol in the Treatment of Tachycardia in Patients With Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.兰地洛尔治疗脓毒症和脓毒性休克患者心动过速的疗效与安全性：一项系统评价和Meta分析

Cureus. 2025 Jul 15;17(7):e88004. doi: 10.7759/cureus.88004. eCollection 2025 Jul.

3

Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J-Land 3S randomised controlled study.患者特征对兰地洛尔治疗脓毒症相关快速性心律失常疗效和安全性的影响：J-Land 3S随机对照研究的亚组分析

EClinicalMedicine. 2020 Oct 13;28:100571. doi: 10.1016/j.eclinm.2020.100571. eCollection 2020 Nov.

4

Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.兰地洛尔治疗脓毒症相关快速性心律失常的疗效和安全性（J-Land 3S）：一项多中心、开放标签、随机对照试验。

Lancet Respir Med. 2020 Sep;8(9):863-872. doi: 10.1016/S2213-2600(20)30037-0. Epub 2020 Mar 31.

5

[The application of landiolol in the cardiovascular and intensive care].兰地洛尔在心血管及重症监护中的应用

Orv Hetil. 2022 Jan 9;163(2):53-62. doi: 10.1556/650.2022.32347.

6

The efficacy of landiolol for suppressing the hyperdynamic response following laryngoscopy and tracheal intubation: a systematic review.兰地洛尔抑制喉镜检查和气管插管后高动力反应的疗效：一项系统评价。

Anaesth Intensive Care. 2009 Nov;37(6):893-902. doi: 10.1177/0310057X0903700621.

7

Effects of landiolol on refractory tachyarrhythmia after total cavopulmonary connection: a retrospective, observational, cohort study.兰地洛尔对全腔静脉肺动脉连接术后难治性快速心律失常的影响：一项回顾性、观察性队列研究。

J Anesth. 2016 Apr;30(2):331-6. doi: 10.1007/s00540-015-2119-4. Epub 2015 Dec 23.

8

Safety and Efficacy of Landiolol Hydrochloride in Children with Tachyarrhythmia of Various Etiologies.盐酸兰地洛尔在各种病因引起的儿童快速性心律失常中的安全性和疗效。

Pediatr Cardiol. 2021 Dec;42(8):1700-1705. doi: 10.1007/s00246-021-02653-7. Epub 2021 Jun 7.

9

Landiolol is effective and safe in paediatric supraventricular tachycardia: evidence from a European prospective multicentre open-label phase III study (LANDI-PED).兰地洛尔治疗小儿室上性心动过速有效且安全：来自一项欧洲前瞻性多中心开放标签III期研究（LANDI-PED）的证据。

Europace. 2025 Feb 5;27(2). doi: 10.1093/europace/euaf025.

10

Landiolol bolus application for tachycardic dysrhythmia in the prehospital EMS setting - An observational study of a novel concept.院前急救医疗服务环境下用于快速性心律失常的单次静脉注射兰地洛尔——一项关于新概念的观察性研究

Scand J Trauma Resusc Emerg Med. 2025 Jul 6;33(1):119. doi: 10.1186/s13049-025-01438-8.

本文引用的文献

1

In vivo effects of cardiomyocyte-specific β-1 blockade on afterload- and frequency-dependent cardiac performance.心肌细胞特异性β-1受体阻断对后负荷和频率依赖性心脏功能的体内效应。

Am J Physiol Heart Circ Physiol. 2025 Mar 1;328(3):H543-H549. doi: 10.1152/ajpheart.00795.2024. Epub 2025 Jan 31.

2

The effects of ultra-selective beta1-antagonism on the metabolic and cytokine profile in septic shock patients receiving noradrenaline: a sub-investigation from the STRESS-L Randomised Study.超选择性β1受体拮抗作用对接受去甲肾上腺素治疗的脓毒性休克患者代谢和细胞因子谱的影响：来自STRESS-L随机研究的一项子研究。

Intensive Care Med Exp. 2025 Jan 22;13(1):9. doi: 10.1186/s40635-024-00708-6.

3